Achieve Life Sciences, Inc. (ACHV)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Achieve Life Sciences, Inc. (ACHV)
Go deeper and ask any question about ACHV
Company Performance
Current Price
as of Sep 13, 2024$4.53
P/E Ratio
N/A
Market Cap
$155.57M
Description
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Metrics
Overview
- HQVancouver, BC
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerACHV
- Price$4.53+4.14%
Trading Information
- Market Cap$155.57M
- Float80.60%
- Average Daily Volume (1m)89,474
- Average Daily Volume (3m)228,631
- EPS-$1.10
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$8.46M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$8.37M
- EV$117.63M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset